13F filer · CIK 2054410
ACORN CAPITAL ADVISORS, LLC
NEW YORK, NY · filing since Q4 2024 · last filing Aug 14, 2026
Reported value
$366.5M
+$14.6M vs prior
Positions
20
New / sold out
1 / 3
Added / reduced
5 / 3
Turnover
5.9%
buys $21.1M · sells $119.1M
Top-10 weight
90.2%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | KARYOPHARM THERAPEUTICS INC | +1,230,287 | +427.4% | +$12.0M |
| Added | JADE BIOSCEINCES INC | +200,000 | +25.4% | +$4.4M |
| Added | AURA BIOSCIENCES INC | +333,333 | +56.0% | +$2.4M |
| New | EUGENE THERAPEUTICS | +1,271,257 | – | +$2.2M |
| Added | CG ONCOLOGY INC | +999 | +0.1% | +$71.0K |
| Added | JASPER THERAPEUTICS | +26,667 | +1.9% | +$11.2K |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | TERNS PHARMACEUTICALS INC | -1,746,264 | -100.0% | $-92.1M |
| Reduced | BIOATLA INC | -5,298,219 | -98.0% | $-21.9M |
| Sold out | CARDIF ONCOLOGY INC | -1,762,084 | -100.0% | $-2.9M |
| Reduced | Q32 BIO INC. | -98,881 | -31.4% | $-1.3M |
| Sold out | X4 PHARMACEUTICALS INC | -234,039 | -100.0% | $-966.6K |
| Reduced | BICARA THERAPEUTICS | -1 | -0.0% | $-30 |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | CG ONCOLOGY INCCOM | 1,131,500 | $80.4M | 21.94% |
| 2 | UROGEN PHARMA LTDCOM | 1,673,420 | $61.6M | 16.80% |
| 3 | TREVI THERAPEUTICS INCCOM | 2,144,844 | $40.0M | 10.92% |
| 4 | CANDEL THERAPEUTICS INCCOM | 3,497,948 | $36.0M | 9.83% |
| 5 | PUMA BIOTECHNOLOGY INCCOM | 4,131,299 | $33.5M | 9.14% |
| 6 | JADE BIOSCEINCES INCCOM NEW | 986,760 | $21.9M | 5.98% |
| 7 | BICARA THERAPEUTICSCOM | 643,381 | $19.1M | 5.21% |
| 8 | KARYOPHARM THERAPEUTICS INCCOMMON STOCK | 1,518,113 | $14.8M | 4.05% |
| 9 | ONKURE THERAPEUTICS INCCLASS A COM | 2,839,674 | $12.9M | 3.53% |
| 10 | HELUS PHARMA INC.COM STK | 1,540,266 | $10.2M | 2.78% |
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.